European Parliament Committee on Public Health
| Committee on Public Health | |
|---|---|
| Abbreviation | SANT |
| Type | Standing committee |
| Legislature | European Parliament |
| Parliamentary term | 10th European Parliament |
| Chair | Adam Jarubas EPP, Poland |
| Vice-Chairs | Tilly Metz (Greens/EFA) Stine Bosse (Renew) Romana Jerković (S&D) Emmanouil Fragkos (ECR) |
| Members | 43 |
| Political composition | EPP: 11 · S&D: 8 · ECR: 5 · Renew: 5 · PfE: 5 · Greens/EFA: 3 · The Left: 3 · ESN: 1 · NI: 2 |
| Established | 2024 |
| Jurisdiction | Public health, pharmaceutical and cosmetic products, medical preparedness, health threats and EU health agencies |
| Website | Official website |
The Committee on Public Health (SANT) is a standing committee of the European Parliament. It is responsible for public-health policy, pharmaceutical and cosmetic products, health preparedness and responses to cross-border health threats, as well as parliamentary scrutiny of the European Medicines Agency and the European Centre for Disease Prevention and Control.[1]
The body was originally created in 2023 as the Subcommittee on Public Health under the Committee on the Environment, Public Health and Food Safety. It later became a separate standing committee during the tenth parliamentary term in 2024, while retaining the abbreviation SANT.[2]
Responsibilities
The committee is responsible for programmes and specific measures in the field of public health, pharmaceutical and cosmetic products, health aspects of bioterrorism and relations with the principal EU agencies responsible for medicines and disease prevention.[3]
Its work includes:
- EU programmes and actions in the field of public health;
- pharmaceutical legislation and access to medicines;
- medical devices and health technologies;
- preparedness for and response to cross-border health threats;
- disease prevention, vaccination policy and antimicrobial resistance;
- mental health and the prevention of non-communicable diseases;
- health aspects of bioterrorism;
- the European Medicines Agency; and
- the European Centre for Disease Prevention and Control.[3][1]
The committee holds exchanges of views with EU agencies, health ministers, researchers and other stakeholders. Its recent work has included medical-device legislation, digital health, youth mental health, biotechnology, cardiovascular disease and oversight of the European Medicines Agency.[2]
History
The Subcommittee on Public Health was created in March 2023 in response to the increased political importance of EU health policy after the COVID-19 pandemic. Its creation followed the work of temporary bodies such as the Special Committee on Beating Cancer and the Special Committee on the COVID-19 pandemic. In the tenth parliamentary term, public-health responsibilities were separated from the environment committee and assigned to SANT as an independent standing committee.[1][2]
Chairs
| Name | Political group | Member state | Took office | Left office | |
|---|---|---|---|---|---|
| Adam Jarubas | EPP |  Poland |
2024 | Incumbent[4] |
Members
10th Parliament, 2024–2029
The committee currently has 43 full members. Its current composition is shown below, with the chair and vice-chairs indicated in italics.[4]
Substitute members
Research support
The committee's work is supported by the European Parliament's research services, which provide studies and briefings on pharmaceutical policy, disease prevention, public-health preparedness, digital health, mental health and health-system resilience.[5]
See also
References
- 1 2 3 "About the Committee on Public Health". European Parliament. Retrieved 11 July 2026.
- 1 2 3 "Committee on Public Health". European Parliament. Retrieved 11 July 2026.
- 1 2 "Powers and responsibilities of the Committee on Public Health". European Parliament. Retrieved 11 July 2026.
- 1 2 3 "Members – Committee on Public Health". European Parliament. Retrieved 11 July 2026.
- ↑ "Supporting analyses – SANT". European Parliament. Retrieved 11 July 2026.
External links
|  | |
| Delegations | ||